| PP110119008185 |
HUTCHMED Ltd., (since Apr 2021), Hutchison China MediTech Limited |
Elunate, Fruzaqla, HMPL-013, TAK-113 |
fruquintinib |
A selectiv.. |
Colorectal.. |
Marketed, Marketed, NDA |
View Details
|
| PP130617011401 |
HUTCHMED Ltd., (since Apr 2021), Hutchison China MediTech Limited |
Orpathys, HMPL-504, AZD6094 |
savolitinib |
A novel, h.. |
Non-small .. |
Marketed, NDA, NDA |
View Details
|
| PP131010011935 |
Hyundai Pharm Co., Ltd. |
HDNO-1605, HOB-047, HD-6277 |
|
A GPR40 ag.. |
Type II di.. |
Phase II |
View Details
|
| PP160119013844 |
HUTCHMED Ltd., (since Apr 2021), Hutchison China MediTech Limited |
HMPL-523 |
sovleplenib |
A selectiv.. |
Idiopathic.. |
NDA, NDA, Phase II, Phase I completed |
View Details
|
| PP160309013969 |
GRI Bio, Inc. |
GRI-0621 |
|
A NKT regu.. |
Idiopathic.. |
Phase II, Phase II |
View Details
|
| PP160527014220 |
Hillhurst Biopharmaceuticals, Inc. |
HBI-002 |
carbon monoxide |
To up-regu.. |
Sickle cel.. |
Phase I, Preclinical, Preclinical |
View Details
|
| PP160527014221 |
Hillhurst Biopharmaceuticals, Inc. |
HBI-137 |
carbon monoxide |
To up-regu.. |
Kidney tra.. |
Preclinical |
View Details
|
| PP160829014778 |
HanAll Biopharma Co., Ltd. |
HL161, RVT-1401, IMVT-1401, HBM9161 |
batoclimab |
An anti-hF.. |
Generalize.. |
NDA, Phase III, Phase II, Phase II, Phase II completed, Phase II, Phase II completed |
View Details
|
| PP160831014791 |
Helsinn Healthcare SA. |
HM01 |
|
A ghrelin .. |
Chemothera.. |
Phase II, Phase II |
View Details
|
| PP160831014793 |
Helsinn Healthcare SA |
HM04 |
|
A ghrelin .. |
Prader-Wil.. |
Phase II |
View Details
|